- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 403/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
Patent holdings for IPC class C07D 403/14
Total number of patents in this class: 8194
10-year publication summary
|
525
|
558
|
547
|
601
|
640
|
617
|
642
|
760
|
561
|
321
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5831 |
162 |
| Bristol-myers Squibb Company | 4898 |
156 |
| Idemitsu Kosan Co., Ltd. | 4219 |
132 |
| Novartis AG | 10849 |
128 |
| F. Hoffmann-La Roche AG | 7925 |
127 |
| Boehringer Ingelheim International GmbH | 4650 |
114 |
| LG Chem, Ltd. | 17632 |
105 |
| Janssen Pharmaceutica N.V. | 3392 |
100 |
| Samsung Display Co., Ltd. | 34696 |
99 |
| Merck Sharp & Dohme LLC | 3748 |
94 |
| Hoffmann-La Roche Inc. | 3418 |
85 |
| Gilead Sciences, Inc. | 2036 |
83 |
| Achillion Pharmaceuticals, Inc. | 164 |
76 |
| Incyte Corporation | 1024 |
67 |
| Pfizer Inc. | 3387 |
66 |
| Genentech, Inc. | 3976 |
64 |
| AstraZeneca AB | 2909 |
63 |
| Amgen Inc. | 4074 |
61 |
| Takeda Pharmaceutical Company Limited | 2713 |
61 |
| Vertex Pharmaceuticals Incorporated | 1597 |
59 |
| Other owners | 6292 |